Dual Trigger Versus Gonadotropin Releasing Hormone Agonist Trigger Combined With Luteal Human Chorionic Gonadotropin Administration

Trial Profile

Dual Trigger Versus Gonadotropin Releasing Hormone Agonist Trigger Combined With Luteal Human Chorionic Gonadotropin Administration

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2017

At a glance

  • Drugs Chorionic gonadotropin (Primary) ; Triptorelin (Primary)
  • Indications Infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Nov 2017 Planned End Date changed from 1 Oct 2017 to 1 Aug 2018.
    • 24 Nov 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Jun 2018.
    • 08 May 2017 Planned End Date changed from 1 Jan 2017 to 1 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top